Topgolf Callaway Brands Corp. (MODG)

Blueprint Medicines Stock Forecast

Stock Price Forecast

The 9 analysts that cover Blueprint Medicines stock have a consensus rating of "Hold" and an average price target of $10.44, which forecasts a 9.21% increase in the stock price over the next year. The lowest target is $7.00 and the highest is $13.

Price Target: $10.44 (+9.21%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$7.00	$10.44	$11	$13
Change	-26.78%	+9.21%	+15.06%	+35.98%

* Price targets were last updated on May 27, 2025.

Analyst Ratings

The average analyst rating for Blueprint Medicines stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	4	3	3	3	3	3
Buy	0	0	0	0	0	0
Hold	6	6	6	6	6	6
Sell	2	2	2	2	2	2
Strong Sell	0	0	0	0	0	0
Total	12	11	11	11	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matthew Boss JP Morgan	JP Morgan	Hold Maintains $8 → $7	Hold	Maintains	$8 → $7	-26.78%	May 27, 2025
Michael Swartz Truist Securities	Truist Securities	Strong Buy Maintains $12 → $7	Strong Buy	Maintains	$12 → $7	-26.78%	Apr 14, 2025
Matthew Boss JP Morgan	JP Morgan	Hold Maintains $9 → $8	Hold	Maintains	$9 → $8	-16.32%	Feb 25, 2025
George Kelly Roth MKM	Roth MKM	Strong Buy Reiterates $16 → $11	Strong Buy	Reiterates	$16 → $11	+15.06%	Feb 25, 2025
Matthew Boss JP Morgan	JP Morgan	Hold Maintains $11 → $9	Hold	Maintains	$11 → $9	-5.86%	Jan 23, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

4.08B

Decreased by -3.71%

from 4.24B

Revenue Next Year

4.19B

Increased by 2.55%

from 4.08B

EPS This Year

-0.50

from -7.88

EPS Next Year

-0.52

from -0.50

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.59B	3.13B	4.00B	4.28B	4.24B	4.08B	4.19B	4.38B
Revenue Growth	-6.56%	97.13%	27.52%	7.23%	-1.06%	-3.71%	2.55%	4.63%
EPS	-1.35	1.82	0.82	0.50	-7.88	-0.50	-0.52	-0.41
EPS Growth	-	-	-55.15%	-38.16%	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	16	15	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	4.3B	4.5B	4.6B
Avg	4.1B	4.2B	4.4B
Low	3.8B	3.7B	4.1B

Revenue Growth

Revenue Growth	2025	2026	2027
High	1.0%	9.0%	10.5%
Avg	-3.7%	2.5%	4.6%
Low	-11.3%	-9.5%	-2.1%

EPS Forecast

EPS	2025	2026	2027
High	0.01	-0.08	-0.25
Avg	-0.50	-0.52	-0.41
Low	-0.68	-0.77	-0.55

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.